Concepedia

Caron Modeas

CM

7

Publications

449

Citations

7

H-Index

1990

Active since

Affiliations

Frontier Science & Technology Research Foundation(Current)

McGill University

Mount Sinai Hospital

Jewish General Hospital

Harvard University

Caron Modeas is an author at Frontier Science & Technology Research Foundation specializing in cancer therapeutics, radiation oncology, and oncology.

Top concepts

Publications per year

1990–1993

7

Publications

7

Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study.

Gary M. Strauss, James E. Herndon, D D Sherman et al. · Journal of Clinical Oncology · 1992 · 213 citations

Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B.

Maria Goutsou, J M Corson, Yota Suzuki et al. · Journal of Clinical Oncology · 1993 · 142 citations

Effect of radiologic stage III substage on nonsurgical therapy of non-small cell lung cancer

Harvey Kreisman, A. Lisbona, Linda K. Olson et al. · Cancer · 1993 · 24 citations

Chemotherapy with 5-fluorouracil (5-FU) and cisplatin or 5-FU, cisplatin, and vinblastine for advanced non-small cell lung cancer. A randomized phase II study of the cancer and leukemia group B

Frederick Richards, David J. Perry, Maria Goutsou et al. · Cancer · 1991 · 23 citations · Full text

Cisplatin-carboplatin therapy in extensive non-small cell lung cancer: a cancer and leukemia group B study

Harvey Kreisman, Maria Goutsou, Caron Modeas et al. · European Journal of Cancer and Clinical Oncology · 1990 · 19 citations

, , +5

Rows per page

1–5 of 7